Home/Pipeline/BAY 2927088

BAY 2927088

Solid tumors

Phase 1Active

Key Facts

Indication

Solid tumors

Phase

Phase 1

Status

Active

Company

Bayer

About Bayer

Bayer AG is one of the world's largest pharmaceutical and life sciences companies, headquartered in Leverkusen, Germany. The company develops and commercializes innovative therapies across oncology, cardiology, ophthalmology, and hematology, while also maintaining leading positions in consumer health products and agricultural sciences. With operations in over 100 countries and approximately 100,000 employees globally, Bayer continues to focus on breakthrough innovations in health and nutrition.

View full company profile

Therapeutic Areas

Oncology Cardiology Ophthalmology Hematology Nephrology Consumer Health

Other Solid tumors Drugs

Drug	Company	Phase	Status
GSK4362676	GSK plc	Phase 1	Active
ABBV-154	AbbVie	Phase 1	Active
TAK-981	Takeda Pharmaceutical	Phase 1/2	Active
TAK-676	Takeda Pharmaceutical	Phase 1	Active
TAK-573	Takeda Pharmaceutical	Phase 1	Active
TAK-164	Takeda Pharmaceutical	Phase 1	Active
SHR-1316	Jiangsu Hengrui Medicine	Phase 1/2	Active
ASP1929	Astellas Pharma	Phase 2	Active
IBI188	Innovent Biologics	Phase 1	Active
Bispecific Antibody	Akeso	Phase 1/2	Active
CSPC-DM02	CSPC Pharmaceutical Group Limited	Phase 2	Active
ONO-4538 combinations	Ono Pharmaceutical	Phase 2	Active